Arcadia Biosciences, Inc.·4

Feb 5, 4:29 PM ET

Schaefer Thomas J. 4

4 · Arcadia Biosciences, Inc. · Filed Feb 5, 2024

Insider Transaction Report

Form 4
Period: 2024-02-01
Schaefer Thomas J.
Chief Executive Officer
Transactions
  • Purchase

    Common Stock

    2024-02-01$2.06/sh+700$1,4421,419 total
Footnotes (2)
  • [F1]Reflects the purchase of 700 shares of the Issuer's common stock on 2/1/24 at a per share purchase price of $2.06 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan ("ESPP"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock.
  • [F2]The amount includes the 2015 Employee Stock Purchase Plan ("ESPP") purchases, for the purchase periods from February 1, 2021 to February 1, 2024. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the date of each respective purchase.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4